BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8182639)

  • 1. Binding characteristics of antitype II collagen antibody to the surface of diseased human cartilage as a probe for tissue damage.
    Noyori K; Koshino T; Takagi T; Okamoto R; Jasin HE
    J Rheumatol; 1994 Feb; 21(2):293-6. PubMed ID: 8182639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics of anti-type II collagen antibody binding to articular cartilage.
    Jasin HE; Noyori K; Takagi T; Taurog JD
    Arthritis Rheum; 1993 May; 36(5):651-9. PubMed ID: 8489543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repair characteristics of the articular cartilage surface following acute inflammatory arthritis.
    Noyori K; Jasin HE
    J Rheumatol; 1994 Sep; 21(9):1731-3. PubMed ID: 7799358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis.
    Kim WU; Yoo WH; Park W; Kang YM; Kim SI; Park JH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY
    J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
    Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
    Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13.
    Wu W; Billinghurst RC; Pidoux I; Antoniou J; Zukor D; Tanzer M; Poole AR
    Arthritis Rheum; 2002 Aug; 46(8):2087-94. PubMed ID: 12209513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
    Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
    Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
    Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
    J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection and immunochemical analysis of type II collagen degradation in human normal, rheumatoid, and osteoarthritic articular cartilages and in explants of bovine articular cartilage cultured with interleukin 1.
    Dodge GR; Poole AR
    J Clin Invest; 1989 Feb; 83(2):647-61. PubMed ID: 2783591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess of metalloproteases over tissue inhibitor of metalloprotease may contribute to cartilage degradation in osteoarthritis and rheumatoid arthritis.
    Martel-Pelletier J; McCollum R; Fujimoto N; Obata K; Cloutier JM; Pelletier JP
    Lab Invest; 1994 Jun; 70(6):807-15. PubMed ID: 8015285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [T cell proliferative response and antibody formation to citrullinated collagen type II in patients with rheumatoid arthritis].
    Tian X; Zhao Y; Li ZG
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):673-6. PubMed ID: 19595060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of disruption of the articular cartilage surface in inflammation. Neutrophil elastase increases availability of collagen type II epitopes for binding with antibody on the surface of articular cartilage.
    Jasin HE; Taurog JD
    J Clin Invest; 1991 May; 87(5):1531-6. PubMed ID: 1708782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lectin-like oxidized low-density lipoprotein receptor 1 mediates matrix metalloproteinase 3 synthesis enhanced by oxidized low-density lipoprotein in rheumatoid arthritis cartilage.
    Kakinuma T; Yasuda T; Nakagawa T; Hiramitsu T; Akiyoshi M; Akagi M; Sawamura T; Nakamura T
    Arthritis Rheum; 2004 Nov; 50(11):3495-503. PubMed ID: 15529384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High CCL18/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritis.
    Momohara S; Okamoto H; Iwamoto T; Mizumura T; Ikari K; Kawaguchi Y; Takeuchi M; Kamatani N; Tomatsu T
    J Rheumatol; 2007 Feb; 34(2):266-71. PubMed ID: 17304652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
    Yasuda T; Poole AR
    Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of collagen type II and proteoglycans in the synovial fluids of patients diagnosed with non-infectious knee joint synovitis indicates early damage to the articular cartilage matrix.
    Elsaid KA; Jay GD; Chichester CO
    Osteoarthritis Cartilage; 2003 Sep; 11(9):673-80. PubMed ID: 12954238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial fluid levels of tumor necrosis factor alpha and oncostatin M correlate with levels of markers of the degradation of crosslinked collagen and cartilage aggrecan in rheumatoid arthritis but not in osteoarthritis.
    Manicourt DH; Poilvache P; Van Egeren A; Devogelaer JP; Lenz ME; Thonar EJ
    Arthritis Rheum; 2000 Feb; 43(2):281-8. PubMed ID: 10693867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic polyarthritis: role of polymorphonuclear leukocytes in the destruction of pannus-free articular cartilage].
    Fehr K; Baici A; Velvart M; Knöpfel M; Rauber M; Sommermeyer G; Salgam P; Cohen G; Böni A
    Bull Schweiz Akad Med Wiss; 1979 Sep; 35(4-6):317-27. PubMed ID: 231468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The distribution of S-100 protein positive chondrocytes in the human articular cartilages under aging or diseased conditions].
    Sugimoto S; Kusuzaki K; Takeshita H; Kuzuhara A; Tsuji Y; Yamashita F; Hirasawa Y; Ashihara T
    Nihon Seikeigeka Gakkai Zasshi; 1991 Oct; 65(10):902-8. PubMed ID: 1770259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.